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Most epidemiological studies done in different 
parts of India have shown the prevalence of Mental 
Retardation (MR) in the general population to vary 
from 3 to 6 per thousand (Verghese et aL 1973; 
Nandi et al, 1980). The psychiatrists' attitude 
towards MR ranges from total indifference to over 
involvement and the attempt to help the mentally 
retarded individuals varies from therapeutic nihilism 
to often unjustifiable use of not only psychotropic 
medication but also uncritical use of remedies which 
claim magical properties. 
In some countries, including our own, a large 
number of r lentally retarded persons are still cared 
for in psychiatric hospitals, although most have no 
need for psychiatric treatment. This wrong place-
ment only reinforces the public attitude of equating 
MR with mental illness. On the other hand in some 
centers in India and many centers in »he West there 
is a tendency to totally demedicalise the care of the 
MR persons. As a result of this, the psychiatrist is 
kept away from participating in the care by non-
medical trainers who often believe that all the MR 
persons need only training programs and parental 
counselling. As Ramey (1994) wrote, psychiatrists 
also treat MR as the Cindrella of psychiatry - one of 
the least glamorous specialisation for a psychiatrist 
to choose as his JT her area of primary interest. Dr. 
Rosha". Masters' Murthi Rao oration published in 
this issue invites our attention to this attitude of the 
professionals to MR As a result of this in all 
countries there is a severe shortage of psychiatrists 
working in the field, a shortage or even absence of 
training opportunities for specialists, lack of scien-
tific research and lack of appreciation of the need for 
a multidisciplinary team approach in the providing 
of services. 
Observations such as that of Mathew et al (1993), 
which show that a significant percentage of MR 
persons have associated psychiatric problems, 
should alert us to the inadvisability of abrogating our 
responsibility in the care of these persons. The care 
of psychiatric problems in MR poses not only special 
problems but also present special challenges and 
opportunities. There is no consensus about the 
phenotypical presentation of classical psychiatric 
syndromes in MR persons or the expression of 
psychopathology in them. Diagnostic systems such 
as ICD X or DSMIV may not be applicable in MR 
or may even be inappropriate. As a result of this, 
there is a danger of either overdiagnosing or under-
diagnosing psychiatric disorders in MR. Develop-
ment of new instruments for assessing 
psychopathology in MR, like the Reiss Screen 
(Reiss & Rojhan, 1993) and Psychiatric Assessment 
Schedule for Adults with a Developmental Dis-
ability (PAS-ADD; Moss et al, 1993) are important 
contributions which have occurred in the recent past. 
Examination of phenomenology of psychiatric 
syndromes associated with MR show that on one 
hand psychiatric disorders may be associated with 
etiologically specific syndromes and on the other 
hand behavioral disturbances that cannot be clas-
sified into one of the existing psychiatric disorders 
(Tuinier & Verhoeven, 1994). Measurement of the 
emotional states of the MR individuals is an area 
which has been paid scant attention though recent-
studies (Lindsay et al, 1994; Harper & Wadsworth, 
1993) have shown that it is possible to objectively 
assess these and mat such assessment can contribute 
greater diagnostic clarity. 
Use of psychotropic drugs in the management of 
psychiatric problems in MR persons is another area 
which deserves attention by psychiatrists. On one 
hand we have situations where little use is made of 
intervention strategies such as behavior modifica-
tion and all problems seen in MR persons are dealt 
withbyindiscriminateuseofneurolepticmecUcation 
which may suppress not only aberrant behavior but 
also behavior in general and thus interfere with their 
rehabilitation. On the other hand we have care givers 
who are almost phobic about the use of medication 
in MR as a result of which those under their care are 
deprived of the benefits of recent advances in the 
pharmacotherapy of psychiatric problems as-
sociated with MR, like risperidone in the treatment 
of behavioral disturbances (Van den Bore et al, 
1993), opiate antagonists in control of self injurious 
behavior (SIB) (Verhoeven et al, 1993) 5 HT re-up-
take inhibitors in the management of SIB (Sovner et 
al, 1993) and Obsessive Compulsive Disorder (Bod-
fish & Madison, 1993). 
Yet another area in which psychiatrists involve-
ment in MR persons can be rewarding is in the study 
of aetiology of MR and development of preventive 
strategies. The observation that in 
phenylketonuria life-long dietary restriction is more 
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beneficial than restrictions for only for the first few 
years of life (Ris et al, 1994); Streissguth and 
Dehaene's (1993) report on Foetal Alcohol 
Syndrome and Viggedal et al (1993) observations on 
the effect of parental exposure to benzodiazepines 
are examples of this. The paper by Prasad et al on 
microcephaly in this issue of the journal is an attempt 
in this direction. 
Thus the challenges that MR, presents to the 
psychiatrist are varied and include developing new, 
as well as adapting existing diagnostic instruments, 
on developing greater understanding of behavioral 
phenotype specification and emotional development 
of individuals' with MR establishing mental health 
care services for the MR population and evolving 
strategies in the rational use of psychotropic drugs 
where they are indicated. Participation in the care of 
the mentally retarded is a responsibility that we as 
psychiatrists should not shirk and is an opportunity 
to gain a better understanding of mental retardation 
and mental health, which we should not miss. 
K.KURUVILLA 
REFERENCES 
Bodfish, J.W. & Madison, J.T. (1993) Diagnosis 
and fluoxetine treatment of compulsive behavior 
disorder of adults with mental retardation. 
American Journal of Mental Retardation, 98, 
360-367. 
Harper, D.C. & Wadsworth, J.S. (1993) Grief in 
adults with mental retardation preliminary find-
ings. Research in Developmental Disabilities, 
14,313-330. 
Lindsay, W.R., Michie, A.M., Baty, FJ., Smith, 
A.H.W. & Miller, S. (1994) The consistency of 
reports about feelings and emotions from people 
with intellectual disability. Journal of Intellec-
tual Disability Research, 38,61-66. 
Mathew, C, Cherian, A., EdwardraJ, S., Mathai, 
G. & Kuruvilla, K. (1993) Role of psychiatrist 
in a center for the management of the mentally 
retarded children. Indian Journal of Psychologi-
cal Medicine, 16,1,35-39. 
Moss, S., PateL P., Prosser, H., Goldberg, D., 
Simpson, N., Rowe, S. & Lucchino, R. (1993) 
Psychiatric morbidity in older people with 
moderate and severe learning disability I. 
Development and Reliability of the Patient inter-
view (PAS-ADD). British Journal of Psychiatry, 
163,471-480. 
Nandi, D.N., Das, N.N., Chaudhuri, A., Banerjee, 
G., Datta, P., Ghosh, A. & Bora!, G.C. (1980) 
Mental morbidity and urban life -an 
epidemiological study. Indian Journal of 
Psychiatry, 22,324-330. 
Ramey, S.L. (1994) Mental Retardation. Current 
Opinion in Psychiatry, 7,371-372. 
Reiss, S. & Rojahn, J. (1993) Joint occurrence of 
depression and aggression in children and adult 
with mental retardation. Journal of Intellectual 
Disability Research, 37, 287-294. 
Ris, M.D., Williams, S.L., Hunt, M.M., Berry, 
H.K. & Leslie, NX. (1994) Early treated 
phenylketonuria: adult neuropsychologic out-
come. Journal of Pediatrics, 124, 388-392. 
Sovner, R., Fox, CJ., Lowry, MJ. & Lowry, 
M.A. (1993) Fluoxetine treatment of depression 
and associated self-injury in two adults with men-
tal retardation. Journal of Intellectual Disability 
Research, 37, 301-311. 
Streissguth, A.P. & Dehaene, A. (1993) Fetal al-
cohol syndrome in twins of alcoholic mother. 
Concordance of diagnosis and IQ. American 
Journal of Medical Genetics, 47,857-861. 
Tuinier, S. & Verhoeven, M.A. (1994) Phar-
macological advances in mental retardation: a 
need for reconceptualisation. Current Opinion in 
Psychiatry, 7,380-386. 
Van den Borne, R., Vennote, R., Buttiens, M., 
Thiry, P., Dierick, G., Geutjens, J., Sieben, G. 
& Heylen, S. (1993) Risperidone as add-on 
therapy in behavioral disturbances in mental 
retardation. Acta Psychiatrica Scandinavica, 87, 
167-171. 
Verghese, A., Beig, A., Senseman, LA., Rao, 
¥SJS. & Benjamin, V. (1973) A social and 
psychiatric study of representative group of 
families in Vellore town. Indian Journal of Medi-
cal Research, 61, 608-620. 
Verhoeven, V.MA., Tuinier, S. & Si n, A.ES. 
(1993) Biological and pharmacological aspects 
of self-injurious behavior. In Merual Health 
Aspects of Mental Retardation, (Eds. 
RJ.Fletcher & ADasen), 291-324. New York: 
Lexington Books. 
Viggedal, G., Hagberg, B.S., Laegread, L. & 
Aronsson, MJ. (1993) Mental development in 
late infancy after prenatal exposure on ben-
zodiazepenes: a prospective study. Journal of 
Child Psychology and Psychiatry, 34,295-306. 
52 